9 in 10 Americans Want Medicare to Cover Alzheimer’s Blood Tests.
A new national poll conducted on behalf of AIM finds, across party lines, Americans want Congress to ensure Medicare coverage of Alzheimer’s screening tests.
Your Impact
Learn how people like you are making a difference in the fight against Alzheimer’s and all dementia.
Our Impact
Alzheimer’s disease is one of the most critical public health issues in America. That’s why the Alzheimer’s Impact Movement (AIM), the Alzheimer’s Association and our advocates are unrelenting. We fight to support Alzheimer's and dementia research funding and advance bipartisan legislation that will have a positive and meaningful impact on people living with Alzheimer's and their caregivers today and in the future.
With the support of volunteer advocates and bipartisan congressional champions we’re making an impact. Help us persuade policymakers to make Alzheimer’s a national priority.
7M
We advocate for the over 7 million Americans living with Alzheimer’s, a progressive and fatal brain disease.
$3.9B
We’ve increased the federal investment in Alzheimer’s and dementia research funding more than seven-fold in the last decade.
13M
Nearly 13 million Americans provide unpaid care for people living with Alzheimer’s or other dementias.
Latest News
AIM Blog
9 in 10 Americans Want Medicare to Cover Alzheimer’s Blood Tests. Congress Should Listen.
Forty years ago, only 14% of women were getting mammograms. The test existed. It worked. But Medicare didn’t cover it, and because Medicare didn’t, private insurers didn’t either. A mammogram was not ...
Alzheimer’s Policy in the States
Across the nation AIM advocates are working to advance public policies to improve the lives of individuals and families impacted by Alzheimer’s and all other dementia. Learn about Alzheimer’s policies and advocacy in your state.